Certificate Course on AI in Drug Development
Conducted by
SOPHAS in Collaboration with Pumas-AI Inc
Duration
8 months (October 2025 to May 2026)
Teaching Methodology
Flipped Classroom approach
Target Audience
Background in statistics, evidence by academic coursework or certification in statistical methods relevant to pharmaceutical sector.
Objectives
- Understand the fundamental concepts of machine learning and their applications in drug development use cases.
- Understand and apply machine learning techniques for covariate modeling and prognostic factor identification.
- Understand and use explainable machine learning techniques to address drug development questions.
- Combine scientific knowledge and neural networks to build scientific machine learning (SciML) pharmacodynamic models.
- Understand the conditional variational autoencoder generative machine learning model and its relationship to nonlinear mixed-effects models.
- Compare pure machine learning, traditional scientific modeling, and hybrid SciML approaches when analyzing longitudinal clinical trial data, with and without random effects.
- Build and use DeepNLME models to analyze disease progression and biomarker data across multiple realistic case studies.
Course Structure
Phase 1:
Structured Virtual Learning
Duration: 5 months (1 Oct 2025 to 28 Feb 2026)
Format: Online, self-paced with guided materials
This phase focuses on building a strong foundational understanding through structured self-paced learning.
Participants will gain:
- Access to recorded lectures, course materials, and licensed software tools for independent study and practice
- Curated readings and learning resources aligned with course outcomes
- Assignments and exercises designed to reinforce core concepts and prepare participants for advanced, hands-on work in later phases
By the end of this phase, learners will be well-equipped with the theoretical background and tools needed for the application-oriented stages of the program.
Phase 2:
Project-Based Learning (Virtual Workshop)
Duration: Mar 2026
An immersive, ten-day virtual workshop combining theoretical instruction with hands-on, project-based learning.
This phase includes:
- In-depth training sessions with Pumas and DeepPumas, advanced software for pharmacometric modeling and scientific machine learning
- Expert-led sessions to reinforce Phase 1 topics with a special focus on applications for drug development.
- A capstone hands-on project and case studies
This intensive workshop equips participants with the practical experience and confidence to apply their knowledge effectively in professional drug development environments.
Phase 3:
Submission and Certification
Duration: 1 month (Dates TBD)
Final Submission: 2nd Week of May 2026
In the final phase of the program, learners will complete their learning journey through project submissions and final assessments.
This phase concludes the program, recognizing participants based on their engagement and performance:
- Certificate of Attendance: For those who complete the virtual learning and attend the in-person workshop.
- Certificate of Completion: For those who submit the capstone project and meet performance criteria.
These certificates formally acknowledge the participant’s proficiency in leveraging artificial intelligence techniques to advance drug development processes and make data-driven decisions.
Topics to be Covered:
Basic concepts
- Definition of “learning”
- Continuous and discrete data
- Data imputation
- Model evaluation
- Cross-validation
- Hyper-parameters
Introduction to Supervised Learning
- Decision tree
- k-nearest neighbors (kNN)
- Ensembles
- Random forest
- Gradient boosting (XGBoost)
Introduction to Unsupervised Learning
- Principal component analysis
- k-means and k-medoids clustering
Neural Network (NN) Essentials
- Universal approximation theorem
- Perceptron
- Activation functions
- Multi-layer perceptron (MLP)
- NNs in supervised learning
- NNs in unsupervised learning
Regularization
- Ridge regression
- LASSO (Least Absolute Shrinkage and Selection Operator)
Neural Networks in Low Data Regime
- Transfer learning
- Self-supervision
- Data augmentation
Time Series Modelling
- Discrete-time NNs (RNN, LSTM, GRU)
- Neural ordinary differential equations (NeuralODEs)
- Universal differential equations (UDEs)
- Scientific machine learning (SciML) for pharmacometrics
Explainability
- SHAPELY (SHapley Additive exPlanations)
- LIME (Local Interpretable Model-agnostic Explanations)
Generative models
- Probabilistic principal component analysis
- Nonlinear mixed effects (NLME) models as generative models
- Variational autoencoder (VAE) as NLME + amortized learning
- Dimension reduction and clustering using generative models
- Normalizing flows
Conditional Generative Models
- Conditional VAE
- Scientific NLME models as conditional generative models
- Generative neural ODEs
- DeepNLME
Model Fitting and Evaluation
- Understanding the marginal likelihood
- Information criteria vs cross-validation
Generative adversarial networks (GANs)
- Adversarial learning and Jensen-Shannon divergence
- Optimal transport and Wasserstein GAN
Instructors

Mohamed Tarek, PhD
Senior Product Engineer, Pumas-AI Inc. Research Affiliate, University of Sydney Business School

Vijay Ivaturi, PhD
Co-Founder & CEO, Pumas-AI Inc. Endowed Chair, Center for Pharmacometrics, Manipal

James Lu, PhD
Senior Principal Investigator, Bioinformatics Institute, A*STAR. Co-Chair, IQ Consortium AI/ML WG. Editorial Board, CPT: Pharmacometrics & Systems Pharmacology

Lucas Pereira, MSc
Product Engineer, Pumas-AI Inc.

Anthony Blaom, PhD
Scientific Computing Consultant, Co-Creator and Lead Contributor to MLJ
Category
|
INR (₹) Fee
|
USD ($) Fee
|
EUR (€) Fee
|
---|---|---|---|
Students
|
₹2,00,000
|
$2,500
|
€2000
|
Academics
|
₹2,50,000
|
$3000
|
€2,500
|
Industry
|
₹4,00,000
|
$4,500
|
€4000
|
Account Name: EVINAHTA CONSULTANCY PRIVATE LIMITED
Account Number: 007205002908
Account Type: Current
IFSC Code: ICIC0000072
Branch: Manipal, Karnataka
*In the Add Note section, please add Full name & Institution/Industry Name & City
Fee Structure (Credit card)*
*2% processing charges added; Click on the Respective Amount to Pay
Registration Form
For group registrations & fee related queries, reach out to us at connect@sophas.net and unlock a smoother, faster onboarding experience.
Upon completing the payment, please ensure you upload the payment proof and enter the Transaction ID in the registration form, along with the other required information.
Call for Sponsors: Advancing the Integration of AI in Drug Development
We are pleased to invite sponsorship for the upcoming eight-months hybrid certificate program in AI in Drug Development. This initiative brings together early-career researchers, professionals, and students from across various countries to build essential, hands-on expertise in a critical area of AI in drug development.
Sponsorship contributions will be directed toward supporting travel and accommodation for course participants attending the in-person workshop (Phase 2) at a Venue in South India (Details to be announced), ensuring broader access and inclusion.
Sponsor Benefits
In recognition of your support, sponsors will receive prominent visibility across all phases of the course through:
- Inclusion of sponsor logos on all official course communications—both digital and print (brochures, certificates, presentation decks, etc.)
- Dedicated shoutouts and acknowledgments on our social media platforms
- On-site recognition during the in-person workshop through banners, displays, and verbal mentions
- Optional engagement opportunities, such as addressing participants or distributing branded materials during the event
We believe that your partnership will not only help foster the next generation of scientific talent but also highlight your organization’s commitment to education and innovation in drug development.
For sponsorship inquiries and customized partnership options, please contact us at connect@sophas.net